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Abstract
Background: Dengue virus is endemic in tropical and sub-tropical resource-poor countries. Dengue illness can range from a
nonspecific febrile illness to a severe disease, Dengue Shock Syndrome (DSS), in which patients develop circulatory failure.
Earlier diagnosis of severe dengue illnesses would have a substantial impact on the allocation of health resources in
endemic countries.
Methods and Findings: We compared clinical laboratory findings collected within 72 hours of fever onset from a
prospective cohort children presenting to one of two hospitals (one urban and one rural) in Thailand. Classification and
regression tree analysis was used to develop diagnostic algorithms using different categories of dengue disease severity to
distinguish between patients at elevated risk of developing a severe dengue illness and those at low risk. A diagnostic
algorithm using WBC count, percent monocytes, platelet count, and hematocrit achieved 97% sensitivity to identify patients
who went on to develop DSS while correctly excluding 48% of non-severe cases. Addition of an indicator of severe plasma
leakage to the WHO definition led to 99% sensitivity using WBC count, percent neutrophils, AST, platelet count, and age.
Conclusions: This study identified two easily applicable diagnostic algorithms using early clinical indicators obtained within
the first 72 hours of illness onset. The algorithms have high sensitivity to distinguish patients at elevated risk of developing
severe dengue illness from patients at low risk, which included patients with mild dengue and other non-dengue febrile
illnesses. Although these algorithms need to be validated in other populations, this study highlights the potential
usefulness of specific clinical indicators early in illness.
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Introduction
Dengue fever (DF) and dengue hemorrhagic fever (DHF), the
more severe form of dengue illness, are re-emerging viral diseases
[1]. Dengue is endemic in countries in tropical and subtropical
areas. Dengue viruses are transmitted through the bite of an
infected mosquito [2]. Illnesses caused by dengue viruses can range
from a nonspecific febrile illness, as in most DF cases, to more
severe illness with bleeding, thrombocytopenia, and plasma
leakage, in cases of DHF [3]. DHF with circulatory failure defines
DHF grades 3 and 4, also termed dengue shock syndrome (DSS)
[3]. However, strict adherence to WHO criteria for diagnosis of
DHF has been difficult and some researchers have established
different categories of severe dengue illnesses [4–7].
Dengue has a substantial economic impact in developing
countries [8,9]. Individuals and families are impacted by lost
wages, cost of seeking care, cost of treatment, missed school, and
extended effects of recovery [8–12]. Prevention and control
strategies have been poorly implemented or unsustained and thus
largely ineffective [13,14].
Currently, there is no licensed vaccine or anti-viral against
dengue. The treatment for patients with suspected dengue is
supportive care consisting of rehydration and anti-pyretics [3].
Patients with suspected dengue are often hospitalized for close
monitoring. Plasma leakage occurs around the time of deferves-
cence. Prior to this critical phase, it has proven difficult to
differentiate mild vs. severe dengue illness. Ideally, only severe
cases of DF and DHF should be hospitalized. However, there are no
diagnostic/prognostic tools available to distinguish severe dengue
from non-severe dengue or other febrile illness (OFI) at early stages
of illness. Such tools could improve clinical practice by decreasing
the number of un-needed hospitalizations, improving utilization of
limited hospital resources to treat more severely ill patients,
improving outcomes of severely ill patients by administering needed
care earlier, and improving the capability of physicians in
developing or rural areas to make a more accurate early diagnosis.
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We conducted a prospective study of Thai children with acute
febrile illness, consistent with dengue, enrolled from an early stage
of illness onset [15]. We applied classification and regression tree
(CART) analysis to this dataset to distinguish patients with severe
dengue illness from those with mild dengue illness and OFI.
CART was used to establish a diagnostic decision tree using
clinical laboratory variables and patient characteristics collected at
presentation.
Methods
Study Setting
A longitudinal observational study was conducted at two
hospitals in Thailand: (1) the Queen Sirikit National Institute of
Child Health (QSNICH) in Bangkok during 1994–97, 1999–2002,
and 2004–07, and (2) the Kamphaeng Phet Provincial Hospital
(KPPH) in the Kamphaeng Phet providence in a rural northern
section of Thailand during 1994–97. The study methods have
been described in detail elsewhere [15]. In brief, children between
the ages of six months and 15 years presenting with temperature
$38uC for no more than 72 hours and no localizing symptoms
were identified in the outpatient department or on the hospital
ward were eligible for enrollment with parental consent. Exclusion
criteria included: signs of shock at presentation, chronic illness, or
an initial alternate non-dengue diagnosis. All subjects were
admitted to the hospital and monitored until 24 hours after
defervescence. Fluid management (oral rehydration or intravenous
fluid) was guided by the ward physician based upon clinical
necessity. The study protocol was approved by the Institutional
Review Boards of all participating institutions.
A blood sample was obtained on the day of enrollment and daily
thereafter until discharge or for a maximum of five consecutive
blood collections. Serological assays (IgM/IgG ELISA and
hemagglutination inhibition assay), virus isolation, and/or RT-
PCR were used to confirm all dengue cases. Patients were
observed and daily clinical and laboratory measurements were
recorded using standardized data collection forms.
After defervescence (2 consecutive temperatures below 38uC),
serial finger-stick hematocrits were measured to capture hemo-
concentration. A right lateral decubitus chest x-ray was taken the
day following defervescence and a pleural effusion index (PEI) was
measured as 1006(maximum width of right pleural effusion)/
(maximum width of right hemithorax). After completion of the
case record, a single expert physician (author S.N.), who was not
directly involved in patient care, assigned a final diagnosis of DF,
DHF, or OFI based upon chart review following WHO guidelines
[3].
Categories of Dengue Illness Severity
Given that not all DHF cases are severe and not all DF cases are
mild, we applied several different categories of dengue disease
severity using data from each patient’s entire hospital course : (1)
dengue shock syndrome (DSS, as defined by WHO criteria); (2)
DSS or PEI.15; (3) DSS or required intravenous fluid; (4) DSS or
platelet count ,=50,000 anytime during illness; (5) DSS or
received fluid intervention (oral or intravenous) in any 24-hour
period that exceeded maintenance volume +5% volume deficit
[16,17].
Clinical Laboratory Variables and Patient Characteristics
The input variables used for establishing each tree were platelet
count, hematocrit, WBC count, percent monocytes, percent
lymphocytes, percent neutrophils, AST, ALT, tourniquet test
(+/2), age, and gender, all of which were obtained on the day of
presentation.
Statistical Analysis
Descriptive characteristics of the study sample were compared
using t-tests and Pearson’s x2. CART analysis was performed
using SPSS Answer Tree 3.0 software (see Text S1) [18]. CART
analysis is a non-parametric analytic tool that has many
advantages over logistic regression models, such as its ability to
detect interaction between variables used to generate a tree
[19,20]. Age, gender, and clinical laboratory data on the day of
presentation were used to establish diagnostic decision trees to
distinguish between patients with severe dengue illness and those
with non-severe illness or OFI. Stopping rules were: (1) no
terminal node could contain ,5% of the original sample size, (2)
no more than 5 levels per tree, and (3) a minimum improvement in
impurity of .0001.
Additional analyses were performed to examine differences in
diagnostic trees according to the day of presentation among the
low risk, non-severe group. The final trees selected were those that
had minimum misclassification of severe dengue illness in low risk
nodes (high sensitivity) and maximum correct classification of non-
severe dengue and OFI in low risk nodes (high specificity). In each
terminal node, patients were classified as low risk or elevated risk
of severe dengue illness where optimal sensitivity could be
achieved. For all analyses, sensitivity was weighted more heavily
than specificity by using misclassification cost ratio of 1:10 severe
dengue vs. non-severe. Each tree was validated using the k-fold
cross validation method [21,22]. We used k= 5 in our analysis.
Results
Study Sample
In total, 1384 patients were enrolled in the study. Of these, 1311
had a final diagnosis of DHF, DF, or OFI. Of the remaining 73
patients, 32 had an undetermined diagnosis due to lack of
convalescent blood sample for serology, and 41 had a presumed
non-viral infection. An additional 81 patients (28 DHF, 20 DF,
Author Summary
Patients with severe dengue illness typically develop
complications in the later stages of illness, making early
clinical management of all patients with suspected dengue
infection difficult. An early prediction tool to identify which
patients will have a severe dengue illness will improve the
utilization of limited hospital resources in dengue endemic
regions. We performed classification and regression tree
(CART) analysis to establish predictive algorithms of severe
dengue illness. Using a Thai hospital pediatric cohort of
patients presenting within the first 72 hours of a
suspected dengue illness, we developed diagnostic
decision algorithms using simple clinical laboratory data
obtained on the day of presentation. These algorithms
correctly classified near 100% of patients who developed a
severe dengue illness while excluding upwards of 50% of
patients with mild dengue or other febrile illnesses. Our
algorithms utilized white blood cell counts, percent white
blood cell differentials, platelet counts, elevated aspartate
aminotransferase, hematocrit, and age. If these algorithms
can be validated in other regions and age groups, they will
help in the clinical management of patients with
suspected dengue illness who present within the first
three days of fever onset.
Early Prediction of Severe Dengue
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and 33 OFI) were missing one or more variables of interest on the
day of presentation and were excluded from the analysis. Table 1
describes the 1230 patients included in the analysis. Among these,
208 had a final physician diagnosis of DHF (53 grade 1, 118 grade
2, 36 grade 3, 1 grade 4), 374 had DF, and 648 had OFI.
Secondary infections accounted for 81.9% of all dengue infections
(74.6% of DF cases and 95.2% of DHF cases). The majority of
dengue infections were DENV1 (40.7%). Table 2 indicates the
number of patients with severe dengue based on different
definitions as well as how trees produced with each of the
definitions (Outcome variable for tree) performed when severity
was defined differently (Outcome variable for evaluation of tree).
Classification Tree for Dengue Shock Syndrome
Trees were generated for each of the five categories of severe
dengue illness. As summarized in Table 2 and shown in Figure 1
(Tree 1), the tree that provided the best distinction on the day of
presentation categorized severe dengue as DSS. The initial
splitting variable in the tree is WBC count; other variables in
the tree include percent monocytes, platelet count, and hemato-
crit. The tree resulted in five terminal nodes, of which three are
considered low risk and two are considered elevated risk. The
three low risk nodes are 1) WBC.8500, 2) WBC,=8500 and
percent monocytes .9.0, and 3) WBC,=8500, percent mono-
cytes,=9.0, platelet count .160200, and hematocrit.40%. The
two nodes considered elevated risk of severe dengue were 1)
WBC,=8500, percent monocytes ,=9.0, and platelet count
,=160200 (64.9% of patients with severe dengue) and 2)
WBC,=8500, percent monocytes,=9.0, platelet count
.160200, and Hct,=40 (32.4% of patients with severe dengue).
A total of 576 (48.3%) patients with non-severe dengue are
classified correctly in the low risk group at the cost of misclassifying
one patient who later manifested DHF grade 3. The initial
splitting variable correctly classified 384 (32%) of the patients with
non-severe dengue. The patients that were correctly classified as
low risk included 63.7% of all OFI, 32.1% of all DF, 41.5% of all
DHF grade 1, and 17.8% of all DHF grade 2. Patients with non-
severe dengue illness were more likely than patients with OFI to be
classified as elevated risk of severe dengue (70.1% of non-severe
dengue versus 36.3% of OFI).
Among the 617 (51.7%) patients with non-severe illness that
were classified as elevated risk, the median day of presentation
was 72 hours after illness onset and the average length of
hospital stay was 6.8 days; patients with non-severe dengue that
were correctly classified had a median day of presentation of
48 hours after illness onset and an average length of hospital
stay of 7.3 days. To assess differences according to the day of
presentation, the tree was applied using data from patients with
non-severe illness at 72 hours among patients who were still
febrile. In this group of low risk patients, the percent correctly
classified as low risk decreased slightly from 48% to 44% (data
not shown).
Classification Tree Using DSS or PEI.15
Figure 2 shows a diagnostic decision tree in which severe disease
was defined as DHF grade 3 or 4 or PEI.15 (Tree 2). This disease
categorization added nine patients with DHF grade 1 and 37
patients with DHF grade 2. No patients diagnosed with OFI or DF
had a PEI.15. For this tree, the initial splitting variable was WBC
count; other variables in the tree include AST, percent neutrophils,
platelet count, and age. There are eight terminal nodes, of which
five are considered low risk and three are considered elevated risk.
The five low risk nodes are 1) WBC.13700, 2) WBC,=13700,
AST 36–50, and platelet count.282000, 3) WBC,=13700, AST
36–50, platelet count ,=282000, and age,=6.75, 4) WBC,=
13700, AST,=35, and percent neutrophils,=68%, and 5)
WBC,=13700, AST,=35, percent neutrophils.68%, and
platelet count.291000. The three elevated risk nodes are 1)
WBC,=13700, AST.50 (72.3% of patients with severe dengue),
2) WBC,=13700, AST 36–50, platelet count ,=282000, and
age.6.75 (16.9% of patients with severe dengue), and 3)
WBC,=13700, AST,=35, percent neutrophils.68%, and
platelet count,=291000 (9.6% of patients with severe dengue).
This tree correctly classified 505 (44%) patients with non-severe
dengue at the cost of misclassifying one patient with severe dengue.
The misclassified patient was diagnosed with DHF grade 2 and
had PEI of 25.8. All patients with DHF grade 3 or grade 4 were
correctly classified in this tree as elevated risk of severe dengue.
Among the 505 patients correctly classified as low risk of severe
dengue, 380 were OFI (58.6% of OFI), 105 were DF (28.1% of
DF), and 20 were DHF grade 1 or 2 (16.0% of non-severe DHF).
Patients with non-severe dengue illness were more likely than
patients with OFI to be classified as elevated risk. When the tree
was applied using data from patients with non-severe illness at
Table 1. Study sample characteristics, in the total sample and by final diagnosis.
Age (mean, 95% CI, years) Gender (m:f ratio)
Days ill at presentation
mean (median)
Length of observational
period (24 hours after
defervescence)
mean(median)*
DHF
Grade 1 (n = 53) 8.4 (7.4, 9.4) 2.3 2.0 (2) 6.2 (6)
Grade 2 (n = 118) 9.1 (8.5, 9.6) 1.3 2.3 (2) 6.4 (6)
Grade 3/4 8.5 (7.6, 9.4) 0.9 2.4 (2) 7.3 (7)***
(n = 37)**
DF (n = 374) 8.6 (8.4, 8.9) 1.1 2.1 (2) 6.3 (6)
OFI (n = 648) 7.1 (6.8, 7.3) 1.2 1.8 (2) 5.3 (5)
*Includes only those patients who remained in the study until the end of the observational period (50 DHF grade1; 110 DHF grade 2; all DHF grade 3 and 4; 327 DF; 495
OFI).
**Only 1 patient had DHF grade 4; this subject was combined with DHF grade 3 for analysis.
***DHF grade 3 or 4 had longer observational periods when compared to patients with DHF grade 1 and 2, DF, or OFI (p,.001).
doi:10.1371/journal.pntd.0000769.t001
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72 hours, the percent of non-severe cases correctly classified as low
risk increased from 44% to 50%.
Classification Tree Using Other Categories of Dengue
Disease Severity
We assessed the generalizability of our trees using other
categories of dengue disease severity (Table 2). For example,
when applying the tree that was generated using DSS as the only
criterion for dengue disease severity (Tree 1) to different categories
of severity, the percentage of patients with a severe dengue illness
that were misclassified as low risk ranged from 12.5% to 17.6%
and the percentage of patients with non-severe illness that were
correctly classified ranged from 48.6% to 52.1%. All additional
trees (Trees 3–5) had moderate specificity but limited sensitivity
(Table 2), with a misclassification of severe dengue as low risk
ranging from 34.9% to 42.6% and a correct classification of non-
severe illness ranging from 72.1% to 81.5%. Each tree shared the
same initial splitting variable of WBC count (data not shown).
Discussion
Early diagnosis of severe dengue illness not only has the potential
to reduce morbidity and mortality, but could also reduce the
economic impact of dengue illness by decreasing the duration of
hospitalization and the number of patients who will develop shock.
We identified two diagnostic algorithms using early clinical
laboratory indicators and patient characteristics that could
distinguish patients with severe dengue from those with non-severe
dengue or other febrile illnesses within the first 72 hours of illness.
When applying these trees to other (broader) categories of
disease severity, a high sensitivity was still achieved. Previous
studies have shown that modified definitions of dengue disease
severity have better agreement with a treating physician’s
Table 2. CART analysis using different categories of severe dengue illness.*
Tree
Outcome variable for
generating tree**
Outcome variable for
evaluation of tree{
% Misclassified severe
dengue (# classified as low
risk/total severe)"
% Correctly classified
non- severe (# classified as
low risk/total non-severe)""
1 Severity Category 1 Severity Category 1 2.7% 48.3%
(1/37) (576/1193)
Severity Category 2 16.9% 49.1%
(14/83) (563/1147)
Severity Category 3 16.8% 51.1%
(25/149) (552/1081)
Severity Category 4 12.5% 52.1%
(20/160) (557/1070)
Severity Category 5 17.6% 48.6%
(12/68) (565/1162)
2 Severity Category 2 Severity Category 1 0.0% 42.2%
(0/37) (504/1193)
Severity Category 2 1.2% 44.0%
(1/83) (505/1147)
Severity Category 3 9.4% 45.5%
(14/149) (492/1081)
Severity Category 4 5.0% 46.5%
(8/160) (498/1070)
Severity Category 5 8.8% 43.0%
(6/68) (500/1162)
3 Severity Category 3 Severity Category 3 34.9% 72.1%
(52/149) (779/1081)
4 Severity Category 4 Severity Category 4 42.5% 81.5%
(68/160) (872/1070)
5 Severity Category 5 Severity Category 5 42.6% 77.3.0%
(29/68) (898/1162)
*Severity Category 1: DSS (DHF grade 3 or 4).
Severity Category 2: DSS or PEI.15.
Severity Category 3: DSS or required intravenous fluid resuscitation during hospitalization.
Severity Category 4: DSS or had min platelet count ,= 50,000 during hospitalization.
Severity Category 5: DSS or received fluid intervention (oral or intravenous) .5% volume deficit above maintenance.
**Severity category used to generate tree.
{Severity category used to evaluate the tree that was generated using another severity category (Column 2).
"‘‘Severe dengue’’ refers to criteria in Column 3.
""‘‘Non-severe dengue’’ refers to criteria in Column 3.
doi:10.1371/journal.pntd.0000769.t002
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assessment when compared to strict adherence to WHO criteria
[4,7,23,24]. For any classification of dengue disease severity
utilized, a high proportion of patients with non-severe dengue or
other febrile illness were correctly classified as low risk of severe
dengue (Table 2). These data suggest that patients classified as
‘elevated risk’ of severe dengue based on these algorithms should
be treated and managed more aggressively; in comparison, our
data suggest that patients classified as ‘low risk’ of severe dengue
could be safely managed on an outpatient basis.
The single patient with severe dengue that was misclassified in
Tree 1 presented within the first 24 hours of illness, had an initial
WBC count of 13700, and was diagnosed with DHF grade 3. Five
other patients with severe dengue in Tree 1 also presented within
the first 24 hours and yet were correctly classified as elevated risk.
When we further investigated the effect of day of presentation by
using day 3 data from all non-severe cases, we found that day of
presentation had little effect on the sensitivity of Trees 1 and 2
(within the first 72 hours); Tree 1 still correctly classified 44% of
the non-severe cases as low risk of severe dengue infection and, in
Tree 2, the percent correctly classified as low risk increased from
44% to 50%.
Many of the variables used in our decision algorithms have been
shown to distinguish between patients with dengue and patients
with OFI in other settings [25]. Trees 1 and 2 have an initial
splitting variable of WBC count, which reinforces the reported
utility of this variable in distinguishing severe dengue illness within
the first days of illness [25–29]. Both trees included nodes using
platelet count as the splitting variable. Thrombocytopenia is a
hallmark of severe dengue disease, although it frequently occurs in
DF as well [3]. Platelet counts are able to distinguish between
patients with dengue and OFI [25,28]. However, when producing
a tree using a minimum platelet count of ,=50,000 as part of the
categorization of severity (Severity category 4), the tree misclassi-
fied 42.5% of patients with severe dengue (Table 2). These data
suggest that thrombocytopenia is not a specific marker for severe
disease in the early febrile phase of dengue illness.
One criticism of CART analysis is that the cutoff values may not
be clinically meaningful. However, when we re-defined the cutoff
values for Trees 1 and 2 the results maintained a high sensitivity.
For example, in Tree 1 when we rounded platelet count to
160,000, the results remained the same. In Tree 2, when we
rounded the cutoffs of platelet count to 290,000 and 280,000,
percent neutrophils to 70%, and age to 7, the tree correctly
classified 45.9% of the non-severe cases while still achieving 94.0%
sensitivity for severe cases.
Interestingly, many of the cutoff lab values in our decision trees
fall within the ‘normal’ range; this suggests that established
‘normal’ ranges for routine laboratory tests have low sensitivity to
detect clinically relevant changes. For example, some variables,
such as hematocrit are normal early in the course of disease but
appear to be able to predict those children who will later develop
severe disease, often associated with hemoconcentration, as seen in
the final node of Tree 1. We interpret this to indicate an
interaction with the outcome of severe dengue and the other
clinical values used in this Tree.
Tanner and colleagues published an analysis establishing
dengue decision trees; however, their analysis was based on only
three WHO-defined DHF cases and it was unclear if these three
cases met other objective criteria for severity [30]. In contrast, our
study has 37 cases of more severe WHO-defined DSS and 171
cases of DHF grade 1 or 2. We also applied other criteria that
could classify patients with dengue as having severe illness. Their
study included a platelet count of ,50,000 as part of the definition
of severe dengue, and the resulting tree was limited in its sensitivity
(82.6%) [30]. Although the tree had a high specificity, sensitivity is
a more important clinical consideration in the detection of severe
Figure 1. CART algorithm #1 for identifying patients who subsequently developed severe dengue (defined as WHO criteria for
dengue shock syndrome, DSS) using clinical laboratory data obtained within the first three days of illness. Each node is shown with
the selected splitting variable, the number of patients with severe/non-severe or OFI, and the proportion of each from the parent node. Terminal
nodes are marked as ‘elevated risk’ of severe dengue illness, outlined in red, and ‘low risk’ of severe dengue, outlined in blue.
doi:10.1371/journal.pntd.0000769.g001
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disease. A more recent decision tree study by Lee and colleagues
found a history of clinical bleeding, serum urea and serum protein
to distinguish between patients with DF and patients with DHF;
however, both studies have limited clinical utility as a predictive
algorithm for patients with severe dengue because virologic
confirmation of dengue infection is not known at presentation
[30,31]. Our study identifies those with severe dengue illness
among all suspected dengue cases.
Our study is subject to some limitations. First, our study
included only pediatric patients at two hospitals in Thailand.
However, because the majority of dengue cases in Thailand and
other regions of Southeast Asia are children, our findings are
Figure 2. CART algorithm #2 for identifying patients who subsequently developed severe dengue (defined as WHO criteria for
dengue shock syndrome, DSS, or dengue with significant pleural effusion) using clinical laboratory data obtained within the first
three days of illness. Pleural effusion index (PEI).15 was used as the criterion for significant pleural effusion. Each node is shown with the selected
splitting variable, the number of patients with severe/non-severe or OFI, and the proportion of each from the parent node. Terminal nodes are
marked as ‘elevated risk’ of severe dengue illness, outlined in red, and ‘low risk’ of severe dengue, outlined in blue.
doi:10.1371/journal.pntd.0000769.g002
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clinically relevant [3,32,33]. Additionally, some patients may have
received early fluid intervention as part of standard care which
may have modified disease progression and development of severe
plasma leakage. Furthermore, because our study enrolled patients
only during the initial 72 hours of illness, these algorithms may not
adequately reflect clinical practice outside of a research setting
where many patients present for medical attention after the first
72 hours of illness. Therefore, we cannot make any conclusions
regarding the sensitivity and specificity of these classification trees
at later time points in illness. We recognize that clinical algorithms
cannot replaced by good clinical management. Further validation
using datasets from additional prospective cohort studies con-
ducted in other dengue endemic regions is needed to establish the
clinical utility of our algorithms in other populations.
We provide two decision tree algorithms using 12 years of
systematically collected clinical data from a well-defined cohort of
pediatric patients in a dengue-endemic region. Our algorithms
have minimal misclassification of WHO-defined DSS cases among
all patients with suspected dengue infection who present within the
first 72 hours of illness. These algorithms also have minimal
misclassification of other severe dengue illnesses using different
categorizations of severity. A robust, validated decision algorithm
can be easily implemented in resource limited settings to identify
patients who are at risk for developing a more severe dengue illness
and limit the number of unneeded hospitalizations.
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